In yesterday’s Wall Street session, Aurora Cannabis Inc. (NASDAQ:ACB) shares traded at $0.86, down -12.19% from the previous session.
As of this writing, 8 analysts cover Aurora Cannabis Inc. (NASDAQ:ACB). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $1.11 and a low of $0.51, we find $0.61. Given the previous closing price of $0.98, this indicates a potential downside of -37.76 percent. ACB stock price is now 55.96% away from the 50-day moving average and 19.06% away from the 200-day moving average. The market capitalization of the company currently stands at $377.16M.
There are 8 analysts who have given it a hold rating, whereas 0 have given it a buy rating. Brokers who have rated the stock have averaged $0.72 as their price target over the next twelve months.
Insiders disposed of 24,206 shares of company stock worth roughly $20817.16 over the past 1 year. A total of 0.11% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ACB stock. A new stake in Aurora Cannabis Inc. shares was purchased by ETF MANAGERS GROUP, LLC during the first quarter worth $7,202,000. PINZ CAPITAL MANAGEMENT, LP invested $516,000 in shares of ACB during the first quarter. In the first quarter, SIG NORTH TRADING, ULC acquired a new stake in Aurora Cannabis Inc. valued at approximately $214,000. GALLAGHER BENEFIT SERVICES, INC. acquired a new stake in ACB for approximately $40,000. FLOW TRADERS U.S. LLC purchased a new stake in ACB valued at around $31,000 in the second quarter.
Monday morning saw Aurora Cannabis Inc. (NASDAQ: ACB) opened at $0.9343. During the past 12 months, Aurora Cannabis Inc. has had a low of $0.43 and a high of $1.62. As of last week, the company has a debt-to-equity ratio of 0.33, a current ratio of 2.30, and a quick ratio of 1.60. The fifty day moving average price for ACB is $0.5596 and a two-hundred day moving average price translates $0.7230 for the stock.
The latest earnings results from Aurora Cannabis Inc. (NASDAQ: ACB) was released for Jun, 2023. The net profit margin was -90.30% and return on equity was -43.50% for ACB.
Aurora Cannabis Inc.(ACB) Company Profile
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company’s adult-use brand portfolio includes Aurora Drift, San Rafael ’71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada.
